Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Vet Med Assoc. 2001 Oct 15;219(8):1110-4.

Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999).

Author information

1
Department of Animal Pathology II, Veterinary Teaching Hospital, School of Veterinary Medicine, Complutense University, Madrid, Spain.

Abstract

OBJECTIVE:

To determine epidemiologic, clinical, and pathologic characteristics of inflammatory mammary carcinoma (IC) in dogs.

DESIGN:

Retrospective study.

ANIMALS:

33 dogs with IC and 153 dogs with malignant mammary tumors other than IC.

PROCEDURES:

Medical records were reviewed, and signalment, history, physical examination findings, and results of thoracic radiography and necropsy were obtained.

RESULTS:

33 of 436 (7.6%) dogs examined at a veterinary teaching hospital because of dysplasia or tumors of the mammary glands and 33 of 186 (17.7%) dogs with at least 1 malignant tumor had IC. Thirty-two of the 33 dogs were sexually intact. Dogs with IC were significantly older than were dogs with other malignant mammary tumors, and in dogs with IC, the tumor was initially noticed a mean of 52 days after the beginning of the last observed estrus, whereas in dogs with other mammary tumors, the tumor was initially noticed a mean of 137 days after the beginning of the last observed estrus. Dogs with IC were more likely to be anorectic and to have generalized weakness, weight loss, and thoracic metastases. Dogs with IC survived a mean of 25 days with palliative treatment. Histologically, involvement of dermal lymphatic vessels was identified in 14 of 19 (74%) dogs with IC. Two clinical forms of IC (primary and secondary) were identified. Dogs with primary IC had a worse clinical condition.

CONCLUSIONS AND CLINICAL RELEVANCE:

Results suggest that IC is an uncommon but distinct entity in dogs. A histologic finding of dermal lymphatic involvement should be considered a hallmark for the pathologic diagnosis of IC in dogs.

PMID:
11700710
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center